Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Apollo Pharmacies Limited, is an unlisted public company incorporated on 08 July, 2016. It is classified as a public limited company and is located in Chennai, Tamil Nadu. It's authorized share capital is INR 145.00 cr and the total paid-up capital is INR 143.50 cr.
Apollo Pharmacies Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 50.81% over the previous year. At the same time, it's book networth has decreased by 228.2%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | - | 5,608.5 | 6,755.2 | 8,258.8 | 9,927.6 |
Operating profit | -0.2 | 280.0 | 254.3 | 125.1 | 228.3 |
Net profit | -0.2 | 18.3 | -27.3 | -282.4 | -176.8 |
Gross margin | - | 20.3 | 19.7 | 19.5 | 20.3 |
Operating margin | - | 5.0 | 3.8 | 1.5 | 2.3 |
Net margin | - | 0.3 | -0.4 | -3.4 | -1.8 |
Networth | -0.1 | 155.4 | 124.0 | -159.0 | -334.7 |
Borrowings | 0.8 | 455.8 | 235.0 | 380.6 | 507.4 |
Assets | 0.7 | 2,137.4 | 2,496.6 | 3,710.9 | 4,314.1 |
Debt to equity | -5.6 | 2.9 | 1.9 | -2.4 | -1.5 |
Current ratio | 0.8 | 1.0 | 0.9 | 0.7 | 0.6 |
ROE | - | 11.8 | -22.0 | - | - |
Days payable | - | 42.0 | 60.0 | 84.0 | 82.0 |
WC days | - | 0.0 | -6.0 | -28.0 | -42.0 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | - | 143.5 | 143.5 | 143.5 | 143.5 |
Reserves | -0.2 | 11.9 | -19.5 | -302.5 | -478.2 |
Borrowings + | 0.8 | 455.8 | 235.0 | 380.6 | 507.4 |
Long term borrowings | - | 226.2 | 217.0 | 186.9 | 141.2 |
Short term borrowings | 0.8 | 229.6 | 18.0 | 193.7 | 366.2 |
Trade payables + | - | 517.5 | 888.4 | 1,526.5 | 1,770.2 |
Days payable | - | 42.0 | 60.0 | 84.0 | 82.0 |
Other liabilities + | - | 1,526.2 | 2,137.6 | 3,489.3 | 4,141.4 |
Other non-current liabilities | - | 748.5 | 926.6 | 1,501.9 | 1,874.3 |
Other current liabilities | - | 260.2 | 322.6 | 460.9 | 496.9 |
Total liabilities | 0.7 | 2,137.4 | 2,496.6 | 3,710.9 | 4,314.1 |
Fixed Assets + | - | 966.5 | 1,179.3 | 1,909.9 | 2,400.5 |
Tangible assets | - | 942.9 | 1,141.4 | 403.1 | 562.5 |
CWIP | - | 4.9 | 16.9 | 1,471.3 | 1,798.3 |
Intangible assets | - | 18.7 | 21.0 | 35.5 | 39.7 |
LT loans and advances | - | - | - | - | - |
Other non-current assets | - | 160.7 | 199.6 | 250.7 | 419.5 |
Current assets + | 0.7 | 1,010.2 | 1,117.7 | 1,550.3 | 1,494.1 |
Inventories | - | 643.9 | 785.0 | 1,032.9 | 1,130.2 |
Trade receivables | - | 170.2 | 227.8 | 261.7 | 211.6 |
Cash and cash equivalents | - | 144.4 | 54.2 | 66.5 | 57.8 |
ST loans and advances | - | - | - | - | - |
Other current assets | 0.6 | 51.7 | 50.6 | 189.2 | 94.5 |
Total assets | 0.7 | 2,137.4 | 2,496.6 | 3,710.9 | 4,314.1 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales + | - | 5,608.5 | 6,755.2 | 8,258.8 | 9,927.6 |
Sales growth % | None | None | 20.45 | 22.26 | 20.21 |
Expenses + | 0.2 | 5,585.2 | 6,795.7 | 8,557.5 | 10,241.5 |
Cost of goods | - | 4,470.6 | 5,421.7 | 6,647.3 | 7,911.3 |
Employee cost | - | 550.7 | 663.6 | 850.6 | 982.9 |
Other costs | 0.2 | 307.2 | 415.6 | 635.8 | 805.1 |
Operating profit + | -0.2 | 280.0 | 254.3 | 125.1 | 228.3 |
Operating margin % | - | 5.0 | 3.8 | 1.5 | 2.3 |
Other income | - | 0.3 | 1.4 | 1.7 | 1.4 |
Interest | - | 102.4 | 119.1 | 179.7 | 240.9 |
Depreciation | - | 154.3 | 175.7 | 244.1 | 301.3 |
Exceptional items | - | - | - | - | - |
Profit before tax | -0.2 | 23.7 | -39.0 | -297.0 | -312.5 |
Tax | - | 5.3 | -11.7 | -14.6 | -135.7 |
Profit - disc. ops | - | - | - | - | - |
Net profit | -0.2 | 18.3 | -27.3 | -282.4 | -176.8 |
Net margin % | - | 0.3 | -0.4 | -3.4 | -1.8 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | -5.6 | 2.9 | 1.9 | -2.4 | -1.5 |
Net Debt/Equity | -5.1 | 2.0 | 1.5 | -2.0 | -1.3 |
Total Debt/Assets | 1.2 | 0.2 | 0.1 | 0.1 | 0.1 |
Total Assets/Equity | -4.7 | 13.8 | 20.1 | -23.3 | -12.9 |
Liquidity + | |||||
Current Ratio | 0.8 | 1.0 | 0.9 | 0.7 | 0.6 |
Quick Ratio | 0.8 | 0.4 | 0.3 | 0.2 | 0.1 |
Interest Coverage | -1,381.3 | 2.7 | 2.1 | 0.7 | 0.9 |
Performance | |||||
Gross Margin | - | 20.3 | 19.7 | 19.5 | 20.3 |
Operating Margin | - | 5.0 | 3.8 | 1.5 | 2.3 |
Net Margin | - | 0.3 | -0.4 | -3.4 | -1.8 |
Return + | |||||
Return on Equity | - | 11.8 | -22.0 | - | - |
Pre-tax ROCE | 110.2 | 13.0 | 7.4 | -9.3 | -5.8 |
Return on Assets | -23.4 | 0.9 | -1.1 | -7.6 | -4.1 |
Pre-tax ROIC | -27.1 | 26.9 | 25.8 | -76.7 | -63.5 |
Efficiency + | |||||
Days Payable | - | 42.0 | 60.0 | 84.0 | 82.0 |
Days Inventory | - | 53.0 | 53.0 | 57.0 | 52.0 |
Days Receivable | 0.0 | 11.0 | 12.0 | 12.0 | 8.0 |
Fixed Asset Turnover | - | 5.8 | 5.7 | 4.3 | 4.1 |
Total Asset Turnover | 0.0 | 2.6 | 2.7 | 2.2 | 2.3 |
Working Capital | |||||
Cash Conversion Cycle | 0.0 | 22.0 | 5.0 | -15.0 | -22.0 |
Working Capital Days | - | 0.0 | -6.0 | -28.0 | -42.0 |
Axis Bank Limited
No. of Loans: 2
Total Amount : 616.5 cr
DBS BANK INDIA LIMITED
No. of Loans: 1
Total Amount : 300.0 cr
IndusInd Bank Limited
No. of Loans: 1
Total Amount : 200.0 cr
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Managing Director | Singana Obul Reddy | 00027829 | 9 years |
Nominee Director | Venkata Chalam Durvasula | 02749496 | 4 years |
Director | Ethiraj Panneerselvam | 08854640 | 5 years |
Director | Mrinalini Reddy Chigullarevu | 08998057 | 4 years |
CS | Virangi D Sheth | <HIDDEN> | 3 years |
CFO | Vinodh Kumar Srinivasan | <HIDDEN> | 3 years |
The incorporation date of APOLLO PHARMACIES LIMITED is 08 July, 2016
The authorized share capital of APOLLO PHARMACIES LIMITED is INR ₹ 145.0 Cr.
The paid-up capital of APOLLO PHARMACIES LIMITED is INR ₹ 143.5 Cr.
The registered address of APOLLO PHARMACIES LIMITED is No.19, Bishop Gardens, Rajaannamalai puram Chennai Chennai Tamil Nadu - 600028
The CIN number of APOLLO PHARMACIES LIMITED is U52500TN2016PLC111328.